ArticlePloS one2020

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa.

Timothy C Nichols et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.